Review
Copyright ©The Author(s) 2017.
World J Gastrointest Oncol. Oct 15, 2017; 9(10): 407-415
Published online Oct 15, 2017. doi: 10.4251/wjgo.v9.i10.407
Table 1 Proportion of periampullary cancer subtypes resected in pancreaticoduodenectomy series
Study (Institution, author, yr)nPancreatic cancerAmpullary cancerBiliary cancerDuodenal cancer
Johns Hopkins, United States He et al[14], 2014256466%16%12%6%
Academic Medical Centre, The Netherlands Tol et al[8], 201576046%30%20%4%
Taipei Veterans General Hospital, Taiwan Chen et al[15], 201350134%50%10%5%
Ohio State University, United States Hatzaras et al[24], 201034672%23%5%0
Oslo University Hospital, Norway Pomianowska et al[16], 201320733%28%14%25%
South Australian Pathology Database, Adelaide, Australia Chandrasegaram et al[6], 201511555%28%15%3%
University Medical Center Groningen, The Netherlands Van Roest et al[25], 200812142%25%16%17%
Leeds Teaching Hospitals NHS Trust, United Kingdom Menon et al[76], 20098333%29%39%N/I
Queen Elizabeth Hospital, Birmingham, United Kingdom Jarufe et al[28], 200425153%35%12%N/I
University of California San Diego, United States Katz et al[17], 200412062%26%8%4%
Table 2 Median survival of patients following resection of periampullary cancers
Study (Institution, author, yr)nMedian survival, mo
Pancreatic cancerAmpullary cancerBiliary cancerDuodenal cancer
Johns Hopkins, United States He et al[14], 2014256419472354
Academic Medical Centre, The Netherlands Tol et al[8], 2015760193629Not reached
Taipei Veterans General Hospital, Taiwan Chen et al[15], 201350113.728.924.421.7
Ohio State University, United States Hatzaras et al[24], 201034617.144.317.9N/I
Queen Elizabeth Hospital, Birmingham, United Kingdom Jarufe et al[28], 200425113.435.516N/I